These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16041155)

  • 21. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina.
    Niccoli G; Biasucci LM; Biscione C; Fusco B; Porto I; Leone AM; Bona RD; Dato I; Liuzzo G; Crea F
    Atherosclerosis; 2008 Feb; 196(2):779-85. PubMed ID: 17306806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention.
    Youssef AA; Chang LT; Sheu JJ; Lee FY; Chua S; Yeh KH; Yang CH; Wu CJ; Yip HK
    Circ J; 2007 Dec; 71(12):1857-61. PubMed ID: 18037736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.
    Szük T; Fejes Z; Debreceni IB; Kerényi A; Édes I; Kappelmayer J; Nagy B
    Platelets; 2016 Jul; 27(5):410-9. PubMed ID: 26765134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis.
    Patel JV; Lim HS; Nadar S; Tayebjee M; Hughes EA; Lip GY
    J Hypertens; 2006 Jan; 24(1):117-21. PubMed ID: 16331109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation.
    Karaca I; Aydin K; Yavuzkir M; Ilkay E; Akbulut M; Isik A; Arslan N
    J Int Med Res; 2005; 33(4):389-96. PubMed ID: 16104442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between C-reactive protein and circulating cell adhesion molecules in patients with unstable angina undergoing coronary intervention and their clinical implication.
    Doo YC; Han SJ; Park WJ; Kim SM; Choi SH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
    Clin Cardiol; 2005 Jan; 28(1):47-51. PubMed ID: 15704532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome.
    Unek IT; Bayraktar F; Solmaz D; Ellidokuz H; Yuksel F; Sisman AR; Yesil S
    Metabolism; 2010 Mar; 59(3):305-13. PubMed ID: 20006362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory response to coronary stent implantation in patients with unstable angina.
    Sánchez-Margalet V; Cubero JM; Martín-Romero C; Cubero J; Cruz-Fernández JM; Goberna R
    Clin Chem Lab Med; 2002 Aug; 40(8):769-74. PubMed ID: 12392302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting.
    Gomma AH; Hirschfield GM; Gallimore JR; Lowe GD; Pepys MB; Fox KM
    Am Heart J; 2004 Jun; 147(6):1071-7. PubMed ID: 15199358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting.
    Doo YC; Han SJ; Han SW; Park WJ; Choi SH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rim CY; Lee KH; Lee Y
    Clin Cardiol; 2005 Feb; 28(2):72-6. PubMed ID: 15757077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.
    Lip GY; Patel JV; Hughes E; Hart RG
    Stroke; 2007 Apr; 38(4):1229-37. PubMed ID: 17332453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.
    Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1477-83. PubMed ID: 16308495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand.
    Liang KW; Sheu WH; Lee WL; Liu TJ; Ting CT; Chen YT; Lee WJ
    Can J Cardiol; 2006 Jun; 22(8):691-6. PubMed ID: 16802000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects.
    Marcaccini AM; Meschiari CA; Sorgi CA; Saraiva MC; de Souza AM; Faccioli LH; Tanus-Santos JE; Novaes AB; Gerlach RF
    J Periodontol; 2009 Apr; 80(4):594-602. PubMed ID: 19335079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases.
    Lee WJ; Sheu WH; Chen YT; Liu TJ; Liang KW; Ting CT; Lee WL
    Thromb Res; 2006; 118(5):619-26. PubMed ID: 16356539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.